Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Capital Expenditures (2021 - 2025)

Historic Capital Expenditures for MDxHealth (MDXH) over the last 4 years, with Q3 2025 value amounting to -$263000.0.

  • MDxHealth's Capital Expenditures fell 2523.81% to -$263000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 17844.7%. This contributed to the annual value of $1.2 million for FY2024, which is 5675.28% down from last year.
  • MDxHealth's Capital Expenditures amounted to -$263000.0 in Q3 2025, which was down 2523.81% from -$364000.0 recorded in Q2 2025.
  • MDxHealth's 5-year Capital Expenditures high stood at $2.2 million for Q4 2024, and its period low was -$568000.0 during Q1 2022.
  • Over the past 4 years, MDxHealth's median Capital Expenditures value was -$263000.0 (recorded in 2025), while the average stood at -$59888.9.
  • The largest annual percentage gain for MDxHealth's Capital Expenditures in the last 5 years was 2523.81% (2025), contrasted with its biggest fall of 2523.81% (2025).
  • MDxHealth's Capital Expenditures (Quarter) stood at -$243000.0 in 2021, then plummeted by 46.91% to -$357000.0 in 2022, then skyrocketed by 711.76% to $2.2 million in 2024, then plummeted by 112.04% to -$263000.0 in 2025.
  • Its Capital Expenditures stands at -$263000.0 for Q3 2025, versus -$364000.0 for Q2 2025 and -$476000.0 for Q1 2025.